REKOO: Rehabilitation Coordinators in Orthopedic Care
Sponsor
Uppsala University (Other)
Overall Status
Completed
CT.gov ID
NCT03944018
Collaborator
(none)
200
1
2
30.8
6.5
Study Details
Study Description
Brief Summary
REKO-O is a study that addressed women and men on sick leave in Uppsala County. Participants which are enrolled in orthopedic care clinic.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
REKO-O is a randomized controlled intervention study that addressed women and men on sick leave in Uppsala County. Participants which are enrolled in orthopedic care clinic
Study Design
Study Type:
Interventional
Actual Enrollment
:
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Rehabilitation Coordinators in Orthopedic Care
Actual Study Start Date
:
Jun 19, 2019
Actual Primary Completion Date
:
Jan 12, 2022
Actual Study Completion Date
:
Jan 12, 2022
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Intervention with rehabilitation coordinator Intervention with rehabilitation coordinator (RECO) |
Behavioral: Intervention with rehabilitation coordinator
Intervention with rehabilitation coordinator in orthopedic care
|
No Intervention: Control TAU |
Outcome Measures
Primary Outcome Measures
- RTW [0.5 year]
Number of Participants that Return to work (RTW)
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 64 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Not recovered in accordance with care plan or cannot be operated and wants an extension of his sick leave
Exclusion Criteria:
-
Obvious medical complications for surgery (wound infection, prosthetic dislocation, stopper or the like)
-
Permanent disability pension
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Uppsala university | Uppsala | Sweden | SE-75122 |
Sponsors and Collaborators
- Uppsala University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Ingrid Anderzen,
associate Professor,
Uppsala University
ClinicalTrials.gov Identifier:
NCT03944018
Other Study ID Numbers:
- REKO-O
First Posted:
May 9, 2019
Last Update Posted:
May 24, 2022
Last Verified:
Oct 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ingrid Anderzen,
associate Professor,
Uppsala University